发明名称 |
ORAL DOSAGE FORM FOR PROPIVERINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS WITH AN EXTENDED RELEASE OF THE ACTIVE INGREDIENT. |
摘要 |
<p>The invention relates to oral pharmaceutical compositions, produced with a suitable controlled-release formula, which contain propiverine, or one or more of its pharmaceutically acceptable salts in a quantity of between 4 and 60 mg propiverine and which exhibit an extended release of the active ingredient. Preferably, a mixture of active ingredient and optionally one or more acidic substances with a pka value of less than 6.65 is provided with a controlled-release coating or is embedded in a matrix and the latter is optionally coated with additional controlled-release layers.</p> |
申请公布号 |
MXPA04003132(A) |
申请公布日期 |
2005.01.25 |
申请号 |
MX2004PA03132 |
申请日期 |
2002.10.08 |
申请人 |
APOGEPHA ARZNEIMITTEL GMBH |
发明人 |
WOLFGANG WEHNER |
分类号 |
A61K9/10;A61K9/14;A61K9/20;A61K9/22;A61K9/28;A61K9/32;A61K9/48;A61K9/50;A61K9/52;A61K31/445;A61K47/12;A61K47/22;A61K47/26;A61K47/32;A61K47/36;A61K47/38;A61K47/42;A61K47/44;A61K47/46;(IPC1-7):A61K9/16 |
主分类号 |
A61K9/10 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|